In human non-small cell lung cancer (NSCLC), overexpression of HIF-1 was found in 32.2% of primary resectable tumors and this was associated with reduced patient survival and increased tumor re-occurrence [18]. Here, HIF1A is linked to non-small cell lung carcinoma.